Mizuho Securities USA’s Bio-Techne TECH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$866K Buy
12,258
+2,800
+30% +$151K 0.01% 607
2026
Q1
$494K Sell
9,458
-1,887
-17% -$113K 0.01% 638
2025
Q4
$732K Sell
11,345
-73
-0.6% -$4.44K 0.01% 626
2025
Q3
$624K Buy
11,418
+579
+5% +$31K 0.01% 643
2025
Q2
$558K Sell
10,839
-1,819
-14% -$91.4K 0.01% 623
2025
Q1
$742K Sell
12,658
-2,401
-16% -$163K 0.02% 573
2024
Q4
$1.08M Buy
15,059
+4,840
+47% +$355K 0.02% 523
2024
Q3
$817K Sell
10,219
-1,927
-16% -$145K 0.02% 534
2024
Q2
$870K Buy
+12,146
New +$894K 0.02% 528

Other funds holding TECH

Mizuho Securities USA's TECH Position: Q2 2026 in Review

Mizuho Securities USA increased its Bio-Techne (TECH) stake by 30% in Q2 2026, buying an estimated $151K and bringing the position to 12,258 shares worth $866K. The position accounts for 0.01% of the portfolio, ranked #607.

Mizuho Securities USA first reported a position in TECH in Q2 2024 and has held it in 9 quarters since. The position peaked at $1.08M in Q4 2024. 593 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

  • Mizuho Securities USA held 12,258 shares of Bio-Techne worth $866K as of Q2 2026.
  • Mizuho Securities USA bought 2,800 Bio-Techne shares in Q2 2026, an estimated $151K.
  • Bio-Techne made up 0.01% of Mizuho Securities USA's portfolio in Q2 2026, its #607 holding.
  • Mizuho Securities USA first reported a position in Bio-Techne in Q2 2024 and has held it in 9 quarters since.
  • Mizuho Securities USA's Bio-Techne position peaked at $1.08M in Q4 2024.
  • 593 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on Mizuho Securities USA's 13F filing for Q2 2026, filed 24 Jul 2026.